Source: AAFP Washington, DC, Office
In a February 26 letter to the U.S. Food and Drug Administration (FDA), the American Academy of Family Physicians and others expressed growing concerns that major tobacco companies are introducing new tobacco products into the marketplace without the regulatory review required by the Family Smoking Prevention and Tobacco Control Act of 2009.
The required premarket review provisions are intended to prevent the tobacco industry from continuing to introduce new tobacco products that are more harmful, more addictive, and more appealing, particularly to young people.
The letter chides the FDA for not taking the actions necessary to remove these products from the market because not doing so represents a serious failure to protect the public health.